Published in Calcif Tissue Int on October 01, 1988
Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest (1993) 1.85
Preoperative vitamin D deficiency predicts postoperative hypocalcemia after total thyroidectomy. World J Surg (2011) 1.76
Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest (1995) 1.46
Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Clin Invest (1990) 1.22
Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors. Mol Cell Endocrinol (2013) 0.96
Hyperparathyroidism and malnutrition with severe vitamin D deficiency. World J Surg (2009) 0.93
Secondary hyperparathyroidism: pathophysiology, histopathology, and medical and surgical management. Surg Today (1997) 0.78
The vitamin D receptor functions as a transcription regulator in the absence of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol (2015) 0.77
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst (1995) 3.79
A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int (2012) 3.62
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int (2008) 3.44
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol (1999) 3.02
Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet (2002) 2.76
Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer (1998) 2.51
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg (2002) 2.41
Epidemiology of renal stones in a middle-aged male population. Acta Med Scand (1975) 2.35
Laparoscopic versus open cholecystectomy: hospitalization, sick leave, analgesia and trauma responses. Br J Surg (1994) 2.34
Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg (1997) 2.21
Pitfalls in the external validation of FRAX. Osteoporos Int (2011) 2.21
A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13
Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys (1992) 2.09
Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med (1995) 2.08
Development and use of FRAX in osteoporosis. Osteoporos Int (2010) 2.04
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. Ann Oncol (2010) 2.02
Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91
Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat (2009) 1.90
Unique clinical characteristics of primary hyperparathyroidism in India. Br J Surg (2001) 1.88
Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens (1995) 1.85
Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation (2000) 1.83
Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol (1997) 1.83
Surgical anatomy of human parathyroid glands. Surgery (1984) 1.81
Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int (2008) 1.77
Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci (2000) 1.74
Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med (2000) 1.73
Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer (1990) 1.73
PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate. J Nucl Med (2000) 1.72
Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab (2000) 1.71
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J (2007) 1.71
Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg (2005) 1.68
Screening for antibodies against gliadin in patients with osteoporosis. J Intern Med (1992) 1.67
Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes (1999) 1.65
Bone metabolism in endurance trained athletes: a comparison to population-based controls based on DXA, SXA, quantitative ultrasound, and biochemical markers. Calcif Tissue Int (1997) 1.61
The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer (1995) 1.60
Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Intern Med (2001) 1.59
Position sense acuity is diminished following repetitive low-intensity work to fatigue in a simulated occupational setting. Eur J Appl Physiol (2000) 1.57
Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery (1987) 1.56
Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial. Br J Surg (2013) 1.56
External hip protectors to prevent osteoporotic hip fractures. Lancet (1997) 1.55
Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest (1997) 1.54
Oral-contraceptive use and risk of hip fracture: a case-control study. Lancet (1999) 1.53
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women. J Clin Oncol (1999) 1.53
Muscle strength correlates with total body bone mineral density in young women but not in men. Scand J Med Sci Sports (2004) 1.52
Estimation of the parenchymal-cell content of the parathyroid gland, using density-gradient columns. Preliminary report. Acta Pathol Microbiol Scand A (1977) 1.52
Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res (1989) 1.50
Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. BMJ (1998) 1.48
Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J Clin Endocrinol Metab (1998) 1.48
Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int (1993) 1.48
Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab (1992) 1.47
Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int (2008) 1.45
Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism. Surgery (1991) 1.45
Screening for osteopenia and osteoporosis: selection by body composition. Osteoporos Int (1996) 1.45
Splenectomy during pregnancy: an option in the treatment of autoimmune thrombocytopenic purpura. Br J Obstet Gynaecol (1999) 1.43
Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery (1997) 1.43
Fasting insulin, calcium metabolism and the electrocardiogram in hypertensive subjects. J Intern Med (1992) 1.42
Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet (1987) 1.42
The burden of hospitalised fractures in Sweden. Osteoporos Int (2004) 1.41
Letter: Renal stones and coronary heart disease. Br Med J (1975) 1.40
Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int (2008) 1.39
Malignant and benign human mammary disease: estrogen binding in relation to clinical data. Cancer (1974) 1.39
The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer (2001) 1.39
Normocalcemic hyperparathyroidism, kidney stones, and idiopathic hypercalciuria. Surgery (1975) 1.38
Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int (2007) 1.38
Tumour location and the effects of preoperative radiotherapy in the treatment of rectal cancer. Br J Surg (2001) 1.37
The potential impact of new National Osteoporosis Foundation guidance on treatment patterns. Osteoporos Int (2009) 1.36
The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology (Oxford) (1999) 1.34
Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anticancer Drugs (2001) 1.33
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant (1997) 1.33
Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab (2000) 1.31
The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int (2006) 1.31
Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.30
Effects of ticlopidine in AV-fistula surgery in uremia. Fistula Study Group. Scand J Urol Nephrol (1998) 1.30
Intracellular application of horseradish peroxidase and its light and electron microscopical appearance in spinocervical tract cells. Brain Res (1976) 1.29
Phosphate status affects the gene expression, protein content and enzymatic activity of UDP-glucose pyrophosphorylase in wild-type and pho mutants of Arabidopsis. Planta (2001) 1.29
The binding of estradiol-17beta to human breast cancers and other tissues in vitro. Cancer Res (1970) 1.27
A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med Devices Artif Organs (1983) 1.25
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int (2010) 1.25
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (2010) 1.24